Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.

Tytuł:
Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.
Autorzy:
Pannek J; Neuro-Urology, Swiss Paraplegic Centre, Guido A. Zäch Strasse 1, CH - 6207, Nottwil, Switzerland. .; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. .
Everaert K; Urologie, Universitair Ziekenhuis, Gent, Belgium.
Möhr S; Schweizerisches Paraplegikerzentrum REHAB, Basel, Switzerland.
Vance W; Urology, Kliniken Beelitz GmbH, Beelitz-Heilstätten, Beelitz, Germany.
Van der Aa F; National Multiple Sclerose Centrum, Melsbroek, Belgium.
Kesselring J; Department of Neurology & Neurorehabilitation, Kliniken Valens, Valens, Switzerland.
Źródło:
BMC urology [BMC Urol] 2020 Jul 08; Vol. 20 (1), pp. 92. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji:
Journal Article; Observational Study
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, [2001-
MeSH Terms:
Biguanides*/administration & dosage
Biguanides*/adverse effects
Catheters, Indwelling*
Disinfectants*/administration & dosage
Disinfectants*/adverse effects
Urinary Catheters*
Aged ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Solutions ; Therapeutic Irrigation/methods
References:
Am J Infect Control. 2018 Jul;46(7):751-757. (PMID: 29478760)
BMC Urol. 2018 May 24;18(1):49. (PMID: 29793457)
Skin Pharmacol Physiol. 2010;23 Suppl:7-16. (PMID: 20829657)
J Hosp Infect. 2016 Nov;94(3):213-227. (PMID: 27671220)
Br J Community Nurs. 2003 Apr;8(4):172-5. (PMID: 12732833)
JAMA. 1982 Jul 23;248(4):454-8. (PMID: 7045440)
Urologe A. 2014 Oct;53(10):1512-7. (PMID: 25249158)
J Urol. 1990 Apr;143(4):717-21. (PMID: 2179582)
Skin Pharmacol Physiol. 2010;23 Suppl:45-51. (PMID: 20829662)
Drugs Aging. 2005;22(10):801-7. (PMID: 16245955)
Skin Pharmacol Physiol. 2010;23 Suppl:17-27. (PMID: 20829658)
J Chin Med Assoc. 2018 Jan;81(1):7-11. (PMID: 29042186)
Br J Community Nurs. 2013 Dec;18(12):588-90. (PMID: 24335791)
Ostomy Wound Manage. 2003 Dec;49(12):34-45. (PMID: 14712009)
J Urol. 1987 Sep;138(3):491-4. (PMID: 3625846)
World J Urol. 2012 Feb;30(1):51-7. (PMID: 21590469)
Spinal Cord. 2010 Nov;48(11):784-90. (PMID: 20368711)
J Adv Nurs. 1996 Mar;23(3):548-54. (PMID: 8655831)
Int Med Case Rep J. 2018 Mar 07;11:53-58. (PMID: 29563843)
Public Health Rep. 2007 Mar-Apr;122(2):160-6. (PMID: 17357358)
J Pharm Pharm Sci. 2017;20(1):397-406. (PMID: 29145934)
J Infect Prev. 2018 May;19(3):123-129. (PMID: 29796094)
Contributed Indexing:
Keywords: Bladder irrigation; Indwelling catheter; Polyhexanide; Urinary tract infection
Molecular Sequence:
ClinicalTrials.gov NCT02157415
Substance Nomenclature:
0 (Biguanides)
0 (Disinfectants)
0 (Solutions)
322U039GMF (polihexanide)
Entry Date(s):
Date Created: 20200710 Date Completed: 20210319 Latest Revision: 20210319
Update Code:
20240105
PubMed Central ID:
PMC7346619
DOI:
10.1186/s12894-020-00650-1
PMID:
32641131
Czasopismo naukowe
Background: In patients with indwelling bladder catheters for > 2 weeks, bacterial colonization is inevitable, leading to urinary tract infections or encrustations with subsequent catheter blockage. Currently, bladder irrigations are the most frequently used prophylactic means, but the best solution remains yet to be determined. In vitro studies demonstrate that polihexanide is a promising option for catheter irrigation, but no data about safety and tolerability exist.
Methods: In a prospective observational study in patients with indwelling bladder catheter for > 2 weeks, a 0.02% polihexanide solution was used to rinse the catheter on five consecutive days. Adverse events, tolerability and vital signs were assessed before, during, after and at the end of the treatment period.
Results: There was no serious adverse event in the study. A total of 28 adverse events (AEs) in 15 (46.88%) participants were experienced. Absolute changes in pain scores were not clinically relevant. No incidences of either flushing or sweating were found during instillation. Bladder spasms during instillation were reported in two cases during a single instillation. Mean pulse rates did not change by more than 3 beats per minute. Mean changes in body temperature did not exceed 0.12 °C. Clinically relevant changes in blood pressure were recorded for 3 patients.
Conclusions: This is the first study to demonstrate that a 0.02% polihexanide solution can safely be used for catheter irrigation.
Trial Registration: ClinicalTrials.gov ( NCT02157415 ), June 6th, 2014.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies